Executive Director, Neuro and Other Rare Value and Access Lead

At Insmed, every moment and every patient counts — and so does every person who joins in. As a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases, you’ll be part of a community that prioritizes the human experience, celebrates curiosity, and values every person’s contributions to meaningful progress. That commitment has earned us recognition as Science magazine’s No. 1 Top Employer for five consecutive years, certification as a Great Place to Work® in the U.S., and a place on The Sunday Times Best Places to Work list in the UK. For patients, for each other, and for the future of science, we’re in. Are you? About the Role: We’re looking for an Executive Director, Neuro and Other Rare Value and Access Lead on the Market Access team to help us expand what’s possible for patients with serious diseases. Reporting to the VP, Head of US Market Access you’ll in this role, you are responsible for developing strategies that ensure innovative therapies for rare and ultra-rare diseases are covered by payers and accessible to patients. This role is responsible for the continuous monitoring of potential opportunities and risks to US payer coverage and provider reimbursement, assessing and recommending appropriate organizational actions to ensure patient access. What You'll Do: In this role, you’ll have the opportunity to lead development of US Neuro and Other Rare Value and Access strategy for launch preparedness, while aligning and contributing to HEOR evidence generation plans to define and deliver long-term value narratives to economic decision makers You’ll also: Partner with Global Program Teams, EMEA and Japan Market Access Teams, Commercial Effectiveness, HEOR, Managed Care, Channel/Trade, Patient Services and Field Access to develop compelling economic narratives, robust value propositions and optimized evidence plans to support access and reimbursement Work with internal teams to align product value with clinical trial design and regulatory strategy Lead strategic pricing assessments and recommendations for Neuro and Other Rare pricing and contracting strategies Lead and influence cross-functional partners and senior business leaders relative to access dynamics and strategy Partner with HEOR and Managed Care leadership to develop evidence-based dossiers that demonstrate the long-term clinical and economic impact of the therapy to payers Coordinate with Managed Care Team to support payer engagement activities, distribution and patient services Develop contracting strategy to secure favorable and profitable coverage while managing payer costs and mitigating risk Monitor policy, reimbursement, and pricing landscape to assess potential business impact Who You Are: You have a Bachelor’s Degree along with 12+ years’ hands-on experience OR a Master's degree plus 10+ Years plus experience in Market Access, HEOR and or Pricing. You are or you also have: Direct experience in Neuro and Other Rare value and access is required Deep understanding of rare diseases, Neuro and Other Rare access dynamics and the US policy landscape (experience in ex-US markets would be preferred but not required) Demonstrated ability to recognize and interpret business issues/opportunities and make/recommend sound business judgments regarding solutions Proficiency in financial modeling, data analysis, and developing value tools (e.g., PowerPoint, Excel). Strong negotiation, cross-functional leadership and communication/presentation skills Excellent communication, collaboration, strategic and analytical skills are required Ability to work optimally in cross-functional teams in a fast-paced, dynamic environment Where You’ll Work This is a fully remote role. It can be performed effectively from anywhere while staying connected to your Insmed team and community. Occasional travel for team meetings or events will be expected. #LI-JTI #LI-Remote Pay Range: $247,000.00-337,000.00 Annual Life at Insmed At Insmed, ... (truncated, view full listing at source)